Form 4: ADC Therapeutics Director Sells Shares to Cover Tax Obligations

Director Viviane Monges sold 1,437 common shares of ADC Therapeutics SA on June 17, 2024, to cover tax withholding obligations related to the vesting and settlement of restricted share units.

Summary

• On June 17, 2024, Viviane Monges, a director of ADC Therapeutics SA, sold 1,437 common shares of the company.
• The sale was executed at a price of $2.89 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted share units.
• Following the transaction, Monges directly owns 106,627 common shares of ADC Therapeutics SA.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company directors and executives.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder perception, but is unlikely to be significant given the reason for the sale.

Key Dates